SCHEMBL6586583

SCHEMBL6586583

O=C(/C=C/c1ccccc1)c1ccc(F)cc1

nearest known ligand 0.82

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TNFRSF1A P19438 3/20 0.82
CYP1B1 Q16678 12/20 0.75
MAOB P27338 6/20 0.75
MAPT P10636 4/20 0.75
PLIN1 O60240 1/20 0.75
LMNA P02545 1/20 0.75
BCHE P06276 1/20 0.75
ACHE P22303 1/20 0.75
RECQL P46063 1/20 0.75
PLIN5 Q00G26 1/20 0.75
ABHD5 Q8WTS1 1/20 0.75
KMT2A Q03164 4/20 0.71
HSPD1 P10809 3/20 0.71
HSPE1 P61604 3/20 0.71
MEN1 O00255 2/20 0.71
MAOA P21397 2/20 0.71
CYP3A4 P08684 2/20 0.71
ALDH2 P05091 1/20 0.71
CYP19A1 P11511 1/20 0.71
F3 P13726 1/20 0.71

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11797296 1.00 TNFRSF1A (0.82) TNFRSF1ACYP1B1MAOBMAPTPLIN1
SCHEMBL6593521 1.00 TNFRSF1A (0.82) TNFRSF1ACYP1B1MAOBMAPTPLIN1
4-Fluoro Chalcone SCHEMBL657887 0.93 TNFRSF1A (0.82) TNFRSF1ACYP1B1MAOBMAPTPLIN1
4-Fluoro Chalcone SCHEMBL657888 0.93 TNFRSF1A (0.82) TNFRSF1ACYP1B1MAOBMAPTPLIN1
4-Fluoro Chalcone SCHEMBL10363601 0.93 TNFRSF1A (0.82) TNFRSF1ACYP1B1MAOBMAPTPLIN1
SCHEMBL7196521 0.90 TNFRSF1A (1.00) TNFRSF1ACYP1B1MAOBMAPTMAOA
SCHEMBL5593308 0.90 TNFRSF1A (1.00) TNFRSF1ACYP1B1MAOBMAPTMAOA
SCHEMBL25221701 0.87 TNFRSF1A (0.86) TNFRSF1ACYP1B1MAOBMAPTPLIN1
SCHEMBL1393290 0.87 TNFRSF1A (0.86) TNFRSF1ACYP1B1MAOBMAPTPLIN1
SCHEMBL1393287 0.87 TNFRSF1A (0.86) TNFRSF1ACYP1B1MAOBMAPTPLIN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113620901-B Crown ether derived chiral 1,1 '-bi-2, 2' -naphthol, preparation method and application thereof 杭州师范大学 2023-02-10 CN claimed
EP-4567018-A1 METHOD FOR PRODUCING FLUORINATED ORGANIC COMPOUND DAIKIN INDUSTRIES, LTD. (JP) 2025-06-11 EP disclosed
CN-119799009-A High-heat-conductivity high-temperature-aging-resistant heat-conducting gel and preparation method thereof 万华化学集团股份有限公司 2025-04-11 CN disclosed
CN-117843626-A Ketone Kangxian-based triazole analogue, and preparation method and application thereof 宿迁晨阳医药科技有限公司 2024-04-09 CN disclosed
CN-117384199-A Preparation of novel organic aluminum hydrogen compound and preparation method of unsaturated alcohol compound catalyzed by novel organic aluminum hydrogen compound 北京理工大学 2024-01-12 CN disclosed
CN-115368268-B Method for efficiently preparing azo compound and application thereof 大连理工大学 2023-11-17 CN disclosed
CN-116284114-A Method for synthesizing chiral 1, 3-phosphine alcohol 陕西师范大学 2023-06-23 CN disclosed
CN-115894345-A Method for photocatalytic synthesis of chiral aza-arene functionalized cyclobutane compound 河南工业大学 2023-04-04 CN disclosed
CN-113620901-B Crown ether derived chiral 1,1 '-bi-2, 2' -naphthol, preparation method and application thereof 杭州师范大学 2023-02-10 CN disclosed
CN-115368268-A Method for efficiently preparing azo compound and application thereof 大连理工大学 2022-11-22 CN disclosed
WO-2001051472-A1 NEW IMIDAZOLE DERIVATIVES ORION CORPORATION (FI) 2001-07-19 WO disclosed
EP-0996432-A2 BIOLOGICALLY ACTIVE 1,3-BIS-AROMATIC-PROP-2-EN-1-ONES, 1,3-BIS-AROMATIC-PROPAN-1-ONES, AND 1,3-BIS-AROMATIC-PROP-2-YN-1-ONES STATENS SERUMINSTITUT (DK) 2000-05-03 EP disclosed
WO-1999000114-A2 BIOLOGICALLY ACTIVE 1,3-BIS-AROMATIC-PROP-2-EN-1-ONES, 1,3-BIS-AROMATIC-PROPAN-1-ONES, AND 1,3-BIS-AROMATIC-PROP-2-YN-1-ONES STATENS SERUM INSTITUT (DK) 1999-01-07 WO disclosed
US-5492915-A ANTIINFLAMMATORY AGENTS RHONE-POULENC RORER S.A. (FR) 1996-02-20 US disclosed
US-5366982-A Antiinflammatory agents or antihistamines RHONE-POULENC RORER S.A. (FR) 1994-11-22 US disclosed
US-5360819-A Nonradioactive labels which provide a ketone signal, vapor phase analysis NORTHEASTERN UNIVERSITY (US) 1994-11-01 US disclosed
EP-0540604-A1 SUBSTITUTED BICYCLIC BIS-ARYL COMPOUNDS EXHIBITING SELECTIVE LEUKOTRIENE B 4? ANTAGONIST ACTIVITY, THEIR PREPARATION AND USE IN PHARMACEUTICAL COMPOSITIONS Aventis Pharma S.A. (FR) 1993-05-12 EP disclosed
WO-1992001675-A2 SUBSTITUTED BICYCLIC BIS-ARYL COMPOUNDS EXHIBITING SELECTIVE LEUKOTRIENE B4 ANTAGONIST ACTIVITY, THEIR PREPARATION AND USE IN PHARMACEUTICAL COMPOSITIONS RHONE-POULENC RORER S.A. (FR) 1992-02-06 WO disclosed
US-5072023-A Reacting lactone with ester anion to form cyclohexenone ester; oxidizing or dehydrogenating the intermediate E. R. SQUIBB & SONS, INC. (US) 1991-12-10 US disclosed
EP-0442495-A1 Process for preparing highly substituted phenyls E.R. SQUIBB & SONS, INC. (US) 1991-08-21 EP disclosed